• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小分子 Pytren-4QMn 金属配合物可减缓雄性 zQ175 转基因小鼠亨廷顿病的进展。

Small Molecule Pytren-4QMn Metal Complex Slows down Huntington's Disease Progression in Male zQ175 Transgenic Mice.

机构信息

Bionos Biotech SL, Biopolo Hospital La Fe, 46026 Valencia, Spain.

Departamento de Química Orgánica e Inorgánica, Instituto de Ciencia Molecular, Universidad de Valencia, 46980 Valencia, Spain.

出版信息

Int J Mol Sci. 2023 Oct 13;24(20):15153. doi: 10.3390/ijms242015153.

DOI:10.3390/ijms242015153
PMID:37894844
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10607077/
Abstract

Huntington's disease (HD) is an inherited neurodegenerative disorder considered a rare disease with a prevalence of 5.7 per 100,000 people. It is caused by an autosomal dominant mutation consisting of expansions of trinucleotide repeats that translate into poly-glutamine enlarged mutant huntingtin proteins (mHTT), which are particularly deleterious in brain tissues. Since there is no cure for this progressive fatal disease, searches for new therapeutic approaches are much needed. The small molecule pytren-4QMn (4QMn), a highly water-soluble mimic of the enzyme superoxide dismutase, has shown in vivo beneficial anti-inflammatory activity in mice and was able to remove mHTT deposits in a C. elegans model of HD. In this study, we assessed 4QMn therapeutic potential in zQ175 neo-deleted knock-in mice, a model of HD that closely mimics the heterozygosity, genetic injury, and progressive nature of the human disease. We provide evidence that 4QMn has good acute and chronic tolerability, and can cross the blood-brain barrier, and in male, but not female, zQ175 mice moderately ameliorate HD-altered gene expression, mHtt aggregation, and HD disease phenotype. Our data highlight the importance of considering sex-specific differences when testing new therapies using animal models and postulate 4QMn as a potential novel type of small water-soluble metal complex that could be worth further investigating for its therapeutic potential in HD, as well as in other polyglutamine diseases.

摘要

亨廷顿病(HD)是一种遗传性神经退行性疾病,被认为是一种罕见病,其患病率为每 10 万人中有 5.7 人。它是由常染色体显性突变引起的,突变由三核苷酸重复扩展组成,导致多谷氨酰胺扩增的突变 huntingtin 蛋白(mHTT),这些蛋白在脑组织中特别有害。由于这种进行性致命疾病尚无治愈方法,因此非常需要寻找新的治疗方法。小分子 pytren-4QMn(4QMn)是一种超氧化物歧化酶的高度水溶性模拟物,已在体内显示出对小鼠有益的抗炎活性,并能够去除 HD 线虫模型中的 mHTT 沉积物。在这项研究中,我们评估了 4QMn 在 zQ175 neo-缺失敲入小鼠中的治疗潜力,zQ175 neo-缺失敲入小鼠是一种模拟人类疾病异质性、遗传损伤和进行性的 HD 模型。我们提供的证据表明,4QMn 具有良好的急性和慢性耐受性,可穿过血脑屏障,并且在雄性但不是雌性 zQ175 小鼠中适度改善 HD 改变的基因表达、mHtt 聚集和 HD 疾病表型。我们的数据强调了在使用动物模型测试新疗法时考虑性别差异的重要性,并假设 4QMn 是一种新型的小水溶性金属配合物,可能具有进一步研究其在 HD 以及其他多谷氨酰胺疾病中的治疗潜力的价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bef3/10607077/75fd6f5d08d4/ijms-24-15153-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bef3/10607077/e0d3dfbcfa6b/ijms-24-15153-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bef3/10607077/58a482625352/ijms-24-15153-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bef3/10607077/011b95a9bf2a/ijms-24-15153-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bef3/10607077/75fd6f5d08d4/ijms-24-15153-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bef3/10607077/e0d3dfbcfa6b/ijms-24-15153-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bef3/10607077/58a482625352/ijms-24-15153-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bef3/10607077/011b95a9bf2a/ijms-24-15153-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bef3/10607077/75fd6f5d08d4/ijms-24-15153-g004.jpg

相似文献

1
Small Molecule Pytren-4QMn Metal Complex Slows down Huntington's Disease Progression in Male zQ175 Transgenic Mice.小分子 Pytren-4QMn 金属配合物可减缓雄性 zQ175 转基因小鼠亨廷顿病的进展。
Int J Mol Sci. 2023 Oct 13;24(20):15153. doi: 10.3390/ijms242015153.
2
Mn(II) Quinoline Complex (4QMn) Restores Proteostasis and Reduces Toxicity in Experimental Models of Huntington's Disease.锰(II)喹啉配合物(4QMn)恢复亨廷顿病实验模型中的蛋白质平衡并降低毒性。
Int J Mol Sci. 2022 Aug 11;23(16):8936. doi: 10.3390/ijms23168936.
3
VGLUT3 Deletion Rescues Motor Deficits and Neuronal Loss in the zQ175 Mouse Model of Huntington's Disease.VGLUT3 缺失可挽救亨廷顿病 zQ175 小鼠模型的运动缺陷和神经元丢失。
J Neurosci. 2023 Jun 7;43(23):4365-4377. doi: 10.1523/JNEUROSCI.0014-23.2023. Epub 2023 Apr 13.
4
Huntingtin silencing delays onset and slows progression of Huntington's disease: a biomarker study.亨廷顿病发病延迟和进展减缓的亨廷顿基因沉默:一项生物标志物研究。
Brain. 2021 Nov 29;144(10):3101-3113. doi: 10.1093/brain/awab190.
5
Downregulation of glial genes involved in synaptic function mitigates Huntington's disease pathogenesis.下调与突触功能相关的神经胶质基因可减轻亨廷顿病的发病机制。
Elife. 2021 Apr 19;10:e64564. doi: 10.7554/eLife.64564.
6
Characterization of Behavioral, Neuropathological, Brain Metabolic and Key Molecular Changes in zQ175 Knock-In Mouse Model of Huntington's Disease.亨廷顿舞蹈病zQ175基因敲入小鼠模型的行为、神经病理学、脑代谢及关键分子变化特征
PLoS One. 2016 Feb 9;11(2):e0148839. doi: 10.1371/journal.pone.0148839. eCollection 2016.
7
Small molecule modulator of protein disulfide isomerase attenuates mutant huntingtin toxicity and inhibits endoplasmic reticulum stress in a mouse model of Huntington's disease.小分子蛋白二硫键异构酶调节剂可减轻亨廷顿病模型小鼠中突变型亨廷顿蛋白的毒性,并抑制内质网应激。
Hum Mol Genet. 2018 May 1;27(9):1545-1555. doi: 10.1093/hmg/ddy061.
8
A selective inhibitor of the NLRP3 inflammasome as a potential therapeutic approach for neuroprotection in a transgenic mouse model of Huntington's disease.NLRP3 炎性小体的选择性抑制剂作为亨廷顿病转基因小鼠模型神经保护的潜在治疗方法。
J Neuroinflammation. 2022 Feb 26;19(1):56. doi: 10.1186/s12974-022-02419-9.
9
mHTT Seeding Activity: A Marker of Disease Progression and Neurotoxicity in Models of Huntington's Disease.mHTT 成核活性:亨廷顿病模型中疾病进展和神经毒性的标志物。
Mol Cell. 2018 Sep 6;71(5):675-688.e6. doi: 10.1016/j.molcel.2018.07.032.
10
Metabotropic Glutamate Receptor 2/3 Activation Improves Motor Performance and Reduces Pathology in Heterozygous zQ175 Huntington Disease Mice.代谢型谷氨酸受体 2/3 的激活可改善杂合 zQ175 亨廷顿病小鼠的运动表现并减少其病理改变。
J Pharmacol Exp Ther. 2021 Oct;379(1):74-84. doi: 10.1124/jpet.121.000735. Epub 2021 Jul 30.

本文引用的文献

1
Mn(II) Quinoline Complex (4QMn) Restores Proteostasis and Reduces Toxicity in Experimental Models of Huntington's Disease.锰(II)喹啉配合物(4QMn)恢复亨廷顿病实验模型中的蛋白质平衡并降低毒性。
Int J Mol Sci. 2022 Aug 11;23(16):8936. doi: 10.3390/ijms23168936.
2
Potential disease-modifying therapies for Huntington's disease: lessons learned and future opportunities.亨廷顿病的潜在疾病修饰治疗方法:经验教训和未来机遇。
Lancet Neurol. 2022 Jul;21(7):645-658. doi: 10.1016/S1474-4422(22)00121-1.
3
Huntington's Disease Clinical Trials Corner: April 2022.
亨廷顿病临床试验角:2022 年 4 月。
J Huntingtons Dis. 2022;11(2):105-118. doi: 10.3233/JHD-229002.
4
Metformin to treat Huntington disease: A pleiotropic drug against a multi-system disorder.二甲双胍治疗亨廷顿病:一种针对多系统紊乱的多效药物。
Mech Ageing Dev. 2022 Jun;204:111670. doi: 10.1016/j.mad.2022.111670. Epub 2022 Mar 30.
5
Temporal Phenotypic Changes in Huntington's Disease Models for Preclinical Studies.亨廷顿病临床前研究模型的时间表表型变化。
J Huntingtons Dis. 2022;11(1):35-57. doi: 10.3233/JHD-210515.
6
Metabotropic Glutamate Receptor 5 Antagonism Reduces Pathology and Differentially Improves Symptoms in Male and Female Heterozygous zQ175 Huntington's Mice.代谢型谷氨酸受体5拮抗剂可减轻雄性和雌性杂合子zQ175亨廷顿病小鼠的病理变化并不同程度改善症状。
Front Mol Neurosci. 2022 Feb 2;15:801757. doi: 10.3389/fnmol.2022.801757. eCollection 2022.
7
Huntington's disease mouse models: unraveling the pathology caused by CAG repeat expansion.亨廷顿舞蹈症小鼠模型:揭示由CAG重复序列扩增引起的病理学机制
Fac Rev. 2021 Oct 21;10:77. doi: 10.12703/r/10-77. eCollection 2021.
8
Oxidative Stress and Neurodegeneration: Interconnected Processes in PolyQ Diseases.氧化应激与神经退行性变:多聚谷氨酰胺疾病中的相互关联过程。
Antioxidants (Basel). 2021 Sep 13;10(9):1450. doi: 10.3390/antiox10091450.
9
Metabotropic Glutamate Receptor 2/3 Activation Improves Motor Performance and Reduces Pathology in Heterozygous zQ175 Huntington Disease Mice.代谢型谷氨酸受体 2/3 的激活可改善杂合 zQ175 亨廷顿病小鼠的运动表现并减少其病理改变。
J Pharmacol Exp Ther. 2021 Oct;379(1):74-84. doi: 10.1124/jpet.121.000735. Epub 2021 Jul 30.
10
FAN1-MLH1 interaction affects repair of DNA interstrand cross-links and slipped-CAG/CTG repeats.FAN1与MLH1的相互作用影响DNA链间交联和滑动的CAG/CTG重复序列的修复。
Sci Adv. 2021 Jul 30;7(31). doi: 10.1126/sciadv.abf7906. Print 2021 Jul.